Insider · CIK 0001613084

Doshi Dipal

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001613084

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−8,724 sh	$7.14	−$62.3K	517,290
2026-03-03	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−19.2K sh	$11.76	−$225K	526,014
2026-03-02	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−9,869 sh	$11.66	−$115K	545,195
2026-03-01	TRDAEntrada Therapeutics, Inc.A Award	Director, CEO	AAward	+139K sh	—	—	555,064
2026-03-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+208K sh	—	—	208,000
2026-02-05	AZTAAzenta, Inc.A Award	Director	AAward	+5,663 sh	$27.85	+$158K	9,703
2025-09-02	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−8,723 sh	$5.43	−$47.4K	415,664
2025-03-03	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−17.6K sh	$11.68	−$205K	424,387
2025-03-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+173K sh	—	—	173,400
2025-03-01	TRDAEntrada Therapeutics, Inc.A Award	Director, CEO	AAward	+116K sh	—	—	441,953
2025-02-07	AZTAAzenta, Inc.A Award	Director	AAward	+4,040 sh	$52.32	+$211K	4,040
2024-09-05	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−826 sh	$15.13	−$12.5K	325,753
2024-09-04	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−4,744 sh	$15.42	−$73.2K	326,579
2024-09-03	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−2,328 sh	$15.76	−$36.7K	332,147
2024-09-03	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−752 sh	$16.93	−$12.7K	331,395
2024-09-03	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−72 sh	$17.70	−$1,274.544	331,323
2024-07-15	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,600 sh	$17.81	−$28.5K	334,475
2024-07-12	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−300 sh	$18.00	−$5,400	336,075
2024-06-13	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$16.17	−$16.2K	336,375
2024-05-17	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,200 sh	$15.11	−$18.1K	337,375
2024-05-16	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,800 sh	$15.00	−$27K	338,575
2024-03-05	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−5,049 sh	$12.28	−$62K	340,375
2024-03-04	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−1,164 sh	$12.42	−$14.5K	346,815
2024-03-04	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−1,391 sh	$13.37	−$18.6K	345,424
2024-03-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+159K sh	—	—	158,500
2024-03-01	TRDAEntrada Therapeutics, Inc.A Award	Director, CEO	AAward	+105K sh	—	—	347,979
2024-02-15	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$15.00	−$15K	243,279
2024-01-16	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$15.99	−$16K	244,279
2023-12-20	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$15.00	−$15K	245,279
2023-11-13	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$16.23	−$16.2K	246,279
2023-10-17	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$15.00	−$15K	247,279
2023-09-13	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$15.00	−$15K	248,279
2023-09-05	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−1,440 sh	$14.46	−$20.8K	249,279
2023-09-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+75.3K sh	—	—	75,250
2023-09-01	TRDAEntrada Therapeutics, Inc.A Award	Director, CEO	AAward	+49.7K sh	—	—	250,719
2023-08-14	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,000 sh	$15.67	−$15.7K	201,069
2023-04-27	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−2,000 sh	$13.71	−$27.4K	202,069
2023-04-17	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−2,092 sh	$18.01	−$37.7K	204,069
2023-03-27	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−1,800 sh	$14.63	−$26.3K	256,011
2023-03-27	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−200 sh	$15.51	−$3,102	255,811
2023-03-02	TRDAEntrada Therapeutics, Inc.F Tax Payment	Director, CEO	FTax Payment	−3,324 sh	$11.60	−$38.5K	257,811
2023-03-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+151K sh	—	—	150,500
2023-03-01	TRDAEntrada Therapeutics, Inc.A Award	Director, CEO	AAward	+49.7K sh	—	—	206,161
2023-03-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+75.3K sh	—	—	75,250
2023-03-01	TRDAEntrada Therapeutics, Inc.A Award	Director, CEO	AAward	+99.3K sh	—	—	261,135
2023-02-28	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−2,000 sh	$12.00	−$24K	161,835
2023-01-27	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−2,000 sh	$12.00	−$24K	163,835
2023-01-09	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−2,410 sh	$15.02	−$36.2K	165,835
2022-12-29	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−400 sh	$15.01	−$6,005.12	168,245
2022-12-28	TRDAEntrada Therapeutics, Inc.S Sale	Director, CEO	SSale	−4,521 sh	$15.01	−$67.9K	168,645

Recent filings

Accepted (ET)
Sep 34
Doshi Dipal0001613084-26-000004
SEC(opens sec.gov)
Mar 34
Doshi Dipal0001613084-26-000001
SEC(opens sec.gov)
Feb 64
Doshi Dipal0001193125-26-041482
SEC(opens sec.gov)
Sep 44
Doshi Dipal0001613084-25-000003
SEC(opens sec.gov)
Mar 44
Doshi Dipal0001689375-25-000015
SEC(opens sec.gov)
Feb 114
Doshi Dipal0000950170-25-017892
SEC(opens sec.gov)
Sep 54
Doshi Dipal0001689375-24-000052
SEC(opens sec.gov)
Jul 164
Doshi Dipal0001689375-24-000040
SEC(opens sec.gov)
Jun 144
Doshi Dipal0001689375-24-000033
SEC(opens sec.gov)
May 204
Doshi Dipal0001689375-24-000030
SEC(opens sec.gov)

Companies

Address

C/O ENTRADA THERAPEUTICS, INC. ONE DESIGN CENTER PLACE, SUITE 17-500

BOSTON, MA, 02210